Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Rank

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Current Allergy and Asthma Reports|February 18, 2015
Assessing the risks and benefits of step-down asthma care: a case-based approachJohn B Hagan, Matthew A Rank
Chest|July 13, 2007
A 38-year-old woman with dyspnea and wheezing following exercise despite asthma therapyMatthew A Rank, Gerald W Volcheck
Chest|July 11, 2021
Bioassays for Objectively Monitoring Systemic Corticosteroid Use in Severe Asthma: Ready for Precision Medicine?John B Hagan, Matthew A Rank
The Journal of Allergy and Clinical Immunology|August 31, 2014
Comparative efficacy and safety of subcutaneous versus sublingual immunotherapyCindy S Bauer, Matthew A Rank
Annals of Internal Medicine|February 2, 2026
In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wkDerek K Chu, Matthew A Rank,
Current Opinion in Allergy and Clinical Immunology|April 11, 2013
Have expert guidelines made a difference in asthma outcomes?Jenna C Podjasek, Matthew A Rank
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 23, 2018
Asthma biologics: Underuse, overuse, and best use?Matthew A Rank, John J Oppenheimer
The Journal of Allergy and Clinical Immunology|February 22, 2008
Beta-blocker prescription in elderly patients with asthmaMatthew A Rank, James T Li
The Journal of Allergy and Clinical Immunology|October 13, 2009
Clinical pearls for preventing, diagnosing, and treating seasonal and 2009 H1N1 influenza infection in patients with asthmaMatthew A Rank, James T Li
Mayo Clinic Proceedings|September 7, 2007
Allergen immunotherapyMatthew A Rank, James T C Li
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Current Allergy and Asthma Reports|February 18, 2015
Assessing the risks and benefits of step-down asthma care: a case-based approachJohn B Hagan, Matthew A Rank
Chest|July 13, 2007
A 38-year-old woman with dyspnea and wheezing following exercise despite asthma therapyMatthew A Rank, Gerald W Volcheck
Chest|July 11, 2021
Bioassays for Objectively Monitoring Systemic Corticosteroid Use in Severe Asthma: Ready for Precision Medicine?John B Hagan, Matthew A Rank
The Journal of Allergy and Clinical Immunology|August 31, 2014
Comparative efficacy and safety of subcutaneous versus sublingual immunotherapyCindy S Bauer, Matthew A Rank
Annals of Internal Medicine|February 2, 2026
In severe chronic rhinosinusitis with polyps and asthma, dupilumab improved nasal polyp score and sense of smell vs. omalizumab at 24 wkDerek K Chu, Matthew A Rank,
Current Opinion in Allergy and Clinical Immunology|April 11, 2013
Have expert guidelines made a difference in asthma outcomes?Jenna C Podjasek, Matthew A Rank
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 23, 2018
Asthma biologics: Underuse, overuse, and best use?Matthew A Rank, John J Oppenheimer
The Journal of Allergy and Clinical Immunology|February 22, 2008
Beta-blocker prescription in elderly patients with asthmaMatthew A Rank, James T Li
The Journal of Allergy and Clinical Immunology|October 13, 2009
Clinical pearls for preventing, diagnosing, and treating seasonal and 2009 H1N1 influenza infection in patients with asthmaMatthew A Rank, James T Li
Mayo Clinic Proceedings|September 7, 2007
Allergen immunotherapyMatthew A Rank, James T C Li
Pageof 14